Part One: Alkaloid Heterotopias

  • J. N. CampbellEmail author
  • Steven M. Rooney
Part of the SpringerBriefs in Molecular Science book series (BRIEFSMOLECULAR)


What went through the mind of Antoine Lavoisier right before the guillotine descended upon his neck, cutting off so much promise as one of the founders of modern chemistry? We cannot help but wonder. Perhaps he was thinking about the experiments he would never get to carry out; maybe he was pondering why his efforts to fight the adulteration of tobacco or to found a Royal Commission on Agriculture had fallen short; or odds on, he was picturing his beautiful and intellectually stimulating wife and collaborator in the laboratory, Marie-Anne, who had steadfastly defended him to the last against the Jacobian steamroller. Lavoisier had the misfortune of being on the wrong side of a revolution that became highly radicalized after the Reign of Terror. Given the opportunity, he could have proffered so much more for the field that fueled both his passion and his marriage.


  1. 1.
    American Chemical Society International Historic Chemical Landmarks (1999) Antoine-Laurent Lavoisier: the chemical revolution, Paris, France, June 8, 1999. Accessed 17 Sept 2017
  2. 2.
    Morris P (2015) The matter factory: a history of the chemistry laboratory. Reaktion, London, pp 47–49, 93–96Google Scholar
  3. 3.
    Donovan A (1993) Antoine Lavoisier: science, administration, and revolution. Cambridge University Press, CambridgeGoogle Scholar
  4. 4.
    Roberts W (1992) Jacques-Louis David, revolutionary artist: art, politics, and the French Revolution. University of North Carolina Press, Chapel HillGoogle Scholar
  5. 5.
    Eagle C, Sloan J (1998) Marie Anne Paulze Lavoisier: the mother of modern chemistry. Chem Educ 3:1–18. Accessed 17 Sept 2017CrossRefGoogle Scholar
  6. 6.
    Eddy M, Mauskopf S, Newman W (eds) (2015) Chemical knowledge in the early modern world. University of Chicago Press, ChicagoGoogle Scholar
  7. 7.
    Cooper A (2007) Inventing the indigenous: local knowledge and natural history in early modern Europe. Cambridge University Press, CambridgeGoogle Scholar
  8. 8.
    Meyer K (2004) Dem morphin auf der spur. Pharmazeutischen Zeitung (in German) GOVI-Verlag. Accessed 15 Sept 2017
  9. 9.
    Booth M (1998) Opium: a history. Simon & Schuster, LondonGoogle Scholar
  10. 10.
    Bentley KW (1954) The chemistry of the morphine alkaloids. Clarendon Press, OxfordGoogle Scholar
  11. 11.
    Lesch R (1981) Conceptual change in an empirical science: the discovery of the first alkaloids. Hist Stud Phys Sci. 11:305–328Google Scholar
  12. 12.
    Vick B (2014) The congress of Vienna: power and politics after Napoleon. Harvard University Press, CambridgeCrossRefGoogle Scholar
  13. 13.
    Rosen W (2017) Miracle cure: the creation of antibiotics and the birth of modern medicine. Viking Press, New York, p 158Google Scholar
  14. 14.
    Hawthorne F (2003) The Merck druggernaut: the inside story of a pharmaceutical giant. Wiley, Hoboken, pp 19–25Google Scholar
  15. 15.
    Ebner F (1968) Merck and Darmstadt: in perspective over the generations. Merck, DarmstadtGoogle Scholar
  16. 16.
    Danna S (2015) Lydia Pinkham: the face that launched a thousand ads. Rowan & Littlefield, New YorkGoogle Scholar
  17. 17.
    Starr P (1982) The social transformation of American medicine: the rise of a sovereign profession and the making of a vast industry. Basic Books, New York, pp 122–123Google Scholar
  18. 18.
    Freedman P (2007) Food: the history of taste. University California Press, BerkeleyGoogle Scholar
  19. 19.
    Laudan R (2015) Cuisine and empire: cooking in world history. University of California Press BerkeleyGoogle Scholar
  20. 20.
    Berridge V, Edwards G (1981) Opium and the people: opiate use in nineteenth-century England. Allen Lane, LondonGoogle Scholar
  21. 21.
    Jansen A (2011) Alexander Dallas Bache: building the American nation through science and education in the nineteenth century. Ger, Campus Verlag, FrankfurtGoogle Scholar
  22. 22.
    Hacker B (ed) (2016) Astride two worlds: technology and the American Civil War. Smithsonian Inst Press, Washington DCGoogle Scholar
  23. 23.
    Courtwright D (2002) Forces of habit: drugs and the making of the modern world. Harvard University Press, CambridgeGoogle Scholar
  24. 24.
    Estes JW (1986) Public pharmacology: modes of action of nineteenth-century ‘patent’ medicines. Medical Heritage 2:218–228PubMedGoogle Scholar
  25. 25.
    Young JH (1967) The medical messiahs: a social history of health quackery in twentieth-century America. Princeton University Press, PrincetonGoogle Scholar
  26. 26.
    Higby G, Stroud E (eds) (2005) American pharmacy (1852–2002), a collection of historical essays. American Institute of Pharmacy, Madison, WIGoogle Scholar
  27. 27.
    Boyle E (2013) Quack medicine: a history of combating health fraud in twentieth-century America. Praeger, Santa Barbara, CAGoogle Scholar
  28. 28.
    Courtwright D (1983) The hidden epidemic: opiate addiction and cocaine use in the South, 1860–1920. J South Hist 49:57–72CrossRefPubMedGoogle Scholar
  29. 29.
    Stage S (1979) Female complaints: Lydia Pinkham and the business of women’s medicine. WW Norton & Co, New YorkGoogle Scholar
  30. 30.
    Courtwright D (2001) Dark paradise: a history of opiate addiction in America. Harvard University Press, CambridgeGoogle Scholar
  31. 31.
    Cowan R (1985) More work for mother: the ironies of household technology from the open hearth to the microwave. Basic Books, New YorkGoogle Scholar
  32. 32.
    Landes D (2003) The unbound prometheus: technological change and industrial development in western Europe from 1750 to the present. Cambridge University Press, CambridgeCrossRefGoogle Scholar
  33. 33.
    Ellis M, Coulton R, Mauger M (2015) Empire of tea: the Asian leaf that conquered the world. Reaktion Books, LondonGoogle Scholar
  34. 34.
    McTavish J (2004) Pain and profits: the history of the headache and its remedies in America. Rutgers University, New BrunswickGoogle Scholar
  35. 35.
    Gabriel J (2014) Medical monopoly: intellectual property rights and the origins of the modern pharmaceutical industry. University of Chicago Press, Chicago, pp 107, 109, 224Google Scholar
  36. 36.
    Day H (1868) The opium habit: with suggestions as to a remedy. Harper and Bros Publishers, New YorkGoogle Scholar
  37. 37.
    Sydenham T (1848) Medical observations concerning the history and cure of acute diseases. In The Works of Thomas Sydenham, M. D. Latham R. G (trans), 2 vols. The Sydenham Society, London 1:29–268Google Scholar
  38. 38.
    Chase AW (1870) Dr. Chase’s recipes, Tenth Ed. R. A. Beal, Ann Arbor, MI, pp 133–134Google Scholar
  39. 39.
    Dick WB (1890) Encyclopedia of practical receipts and processes. Fifth Ed. Dick & Fitzgerald Publishers, New York, pp 416, 447, 472Google Scholar
  40. 40.
    Veblen T (1994) The theory of the leisure class: an economic study of institutions. Penguin Twentieth-Century Classics. Intro R Lekachman. Penguin Books, New YorkGoogle Scholar
  41. 41.
    Kisskalt K (1948) Max von Pettenkoffer. Wissenschaftlichen Verlag, StutgartGoogle Scholar
  42. 42.
    Billinger RD (1939) The Chandler influence in American chemistry. J Chem Ed 16:253–257CrossRefGoogle Scholar
  43. 43.
    Adas M (1991) Machines as the measure of men: science, technology, and ideologies of western dominance Ithaca: Cornell University PressGoogle Scholar
  44. 44.
    Rosenberg C (1979) The therapeutic revolution: medicine, meaning and social change in nineteenth century America. In: Vogel M, Rosenberg C (eds) The therapeutic revolution: essays in the social history of American medicine. Univ Penn Press, Philadelphia, pp 3–25Google Scholar
  45. 45.
    Kohler R (1982) From medical chemistry to biochemistry: the making of a biomedical discipline Cambridge: Cambridge University Press, pp 9–19Google Scholar
  46. 46.
    Rabinbach A (1992) The human motor energy fatigue and the origins of modernity. University California Press, BerkeleyGoogle Scholar
  47. 47.
    Rosenberg C (1992) Explaining epidemics and other studies in the history of medicine. Cambridge University Press, CambridgeCrossRefGoogle Scholar
  48. 48.
    Brock W (2002) Justus von Liebig: the chemical gatekeeper. Cambridge, New YorkGoogle Scholar
  49. 49.
    Gerritsen A, Riello G (2015) Writing material culture history. Bloomsbury Academic, LondonGoogle Scholar
  50. 50.
    Egbert M (1991) Scientists’ orientation to an experimental apparatus in their interaction in a chemistry lab. Issues Appl Linguist 2(2):269–300Google Scholar
  51. 51.
    Hofmann AW (1866) The chemical laboratories in course of erection in the Universities of Bonn and Berlin. W. Clowes and Sons, London, p 8Google Scholar
  52. 52.
    Day C (2017) Consumptive chic: a history of beauty, fashion, and disease. Bloomsbury Academic, LondonGoogle Scholar
  53. 53.
    Perren R (2006) Taste trade and technology the development of the international meat industry since 1840. Ashgate Publishing, Burlington, VTGoogle Scholar
  54. 54.
    Bell S (2015) New frontiers and natural resources in southern south America, c. 1820–1870: examples from northwest European mercantile enterprise. In: Trading environments: frontiers, commercial knowledge an environmental transformation, 1750–1990. Winder G and Dix A (eds) Routledge, New York, pp 47–68Google Scholar
  55. 55.
    Travis A (1990) Perkin’s mauve: ancestor of the organic chemical industry. Technol Cult 31:51–80CrossRefGoogle Scholar
  56. 56.
    Travis A (1993) The rainbow makers: the origins of the synthetic dyestuff industry in western Europe. Lehigh Univ Press, Bethlehem, PA, pp 35–44Google Scholar
  57. 57.
    Beer J (1959) The emergence of the German dye industry. University Illinois Press, Urbana, IllGoogle Scholar
  58. 58.
    Meyer-Thurow G (1982) The industrialization of invention: a case study from the German chemical industry. Isis 73:363–381CrossRefPubMedGoogle Scholar
  59. 59.
    Travis A, Hornix W, Bud R, Homburg E (1992) The emergence of research laboratories in the dyestuffs industry, 1870–1900. Brit J Hist Sci 25(1):91–111CrossRefGoogle Scholar
  60. 60.
    Stock A (1935) Carl Dusiberg: 29.9.1861–19.3.1935. Ber Dtsch Chem Ges 68(11):A111–A148Google Scholar
  61. 61.
    Galambos L (1997) Networks of innovation: vaccine development at Merck, Sharp and Dohme, and Mulford, 1895–1995. Cambridge University Press, CambridgeGoogle Scholar
  62. 62.
    Wimmer W (1998) Innovation in the German pharmaceutical industry, 1880 to 1920. In: Homburg E et al (eds) The chemical industry in Europe, 1850–1914: industrial growth, pollution, and professionalization. Kluwer Academic Publishers, Dordrecht, pp 281–292CrossRefGoogle Scholar
  63. 63.
    Rooney S, Campbell JN (2017) How aspirin entered our medicine cabinet. Springer Publishing, HeidelbergCrossRefGoogle Scholar
  64. 64.
    Lenoir T (1988) A magic bullet: research for profit and the growth of knowledge in Germany around 1900. Minerva 26:66–88CrossRefGoogle Scholar
  65. 65.
    Fernandez H, Libby T (2011) Heroin: its history, pharmacology, and treatment, 2nd edn. Hazelden Center City, MNGoogle Scholar
  66. 66.
    Liebenau J (1987) Medical science and medical industry: the formation of the American pharmaceutical industry. Johns Hopkins University Press, BaltimoreCrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Independent ScholarSpringUSA
  2. 2.Independent ScholarIrvingUSA

Personalised recommendations